anti-amyloid immunotherapyAlzheimer’s diseaseoral anticoagulantsADEuropean UnionAnti-amyloid monoclonal antibodiesEU
…option in early Alzheimer’s disease (AD). In patients receiving anti-amyloid immunotherapy, Aβ removal-associated blood-brain barrier damage and perivascu…